Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ: VRCA · IEX Real-Time Price · USD

6.98

+0.08 (1.16%)

At close: Apr 19, 2024, 4:00 PM

7.10

+0.12 (1.72%)

After-hours: Apr 19, 2024, 5:00 PM EDT

Verrica Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-67	-24.49	-35.08	-42.69	-28.21	-20.65	-9.76	-1.91
Depreciation & Amortization	0.84	0.72	0.47	0.23	0.26	0.02	0	0
Share-Based Compensation	14.38	4.99	6.05	9.82	3.33	2.25	0.08	0.01
Other Operating Activities	13.21	0.13	0.97	2.44	-2.79	0.5	-0.21	0.29
Operating Cash Flow	-38.58	-18.65	-27.58	-30.21	-27.41	-17.87	-4.58	-1.61
Capital Expenditures	-0.36	-0.3	-0.88	-1.47	-0.68	-0.77	0	0
Change in Investments	0	54.34	-0.12	-2.11	26.64	-79.12	0	0
Investing Cash Flow	-0.36	54.04	-1	-3.58	25.96	-79.89	0	0
Share Issuance / Repurchase	30.31	26.9	28.68	0.45	0.42	78.38	0	0
Debt Issued / Paid	44.08	-43.77	4.97	34.37	0	0	0	0
Other Financing Activities	-0.18	-	-	0.41	-	20.99	12.72	0.48
Financing Cash Flow	74.21	-16.87	33.65	35.23	0.42	99.38	12.72	0.48
Net Cash Flow	35.27	18.52	5.07	1.45	-1.03	1.61	8.14	-1.13
Free Cash Flow	-38.94	-18.95	-28.47	-31.68	-28.09	-18.65	-4.58	-1.61
Free Cash Flow Margin	-759.93%	-209.83%	-237.21%	-	-	-	-	-
Free Cash Flow Per Share	-0.86	-0.56	-1.05	-1.27	-1.13	-1.27	-1.61	-0.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).